✦ LIBER ✦

Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes

✍ Scribed by Y.-F. Shi; C.-Y. Pan; J. Hill; Y. Gao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Orlistat reduces the risk of type 2 diab

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Acute effect of orlistat on postprandial

✍ Tan, K.C.B.; Tso, A.W.C.; Tam, S.C.F.; Pang, R.W.C.; Lam, K.S.L. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Insulin management in overweight or obes

✍ M. Davies; K. Khunti 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Dynamic evaluation of renal resistive in

✍ R. M. Bruno; E. Daghini; L. Landini; D. Versari; A. Salvati; E. Santini; I. Di P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 418 KB

Time to treatment initiation with oral a

✍ Q. Zhang; S. Rajagopalan; E. Marrett; M. J. Davies; L. Radican; S. S. Engel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 583 KB

Efficacy and tolerability of rimonabant

✍ André J Scheen; Nick Finer; Priscilla Hollander; Michael D Jensen; Luc F Van Gaa 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 217 KB